Health Condition 1: I251- Atherosclerotic heart disease of native coronary artery
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Adults aged 18 years and above Patients who underwent percutaneous coronary intervention using either drug eluting balloon or drug eluting stent Patients diagnosed with coronary artery disease including stable angina unstable angina NSTEMI or STEMI Availability of complete clinical procedural and angiographic records Procedures performed at the study center within the defined study period
Exclusion criteria
Exclusion criteria: Patients with incomplete or missing clinical procedural or angiographic data Patients presenting with cardiogenic shock at the time of intervention Patients with concomitant structural heart disease requiring intervention Patients who underwent hybrid procedures involving both drug eluting balloon and drug eluting stent in the same lesion Patients with prior percutaneous coronary intervention to the same lesion during the study period
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of major adverse cardiac events including all cause mortality myocardial infarction and target lesion revascularizationTimepoint: Baseline, 52 Weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Procedural success rate defined as successful completion of percutaneous coronary intervention without major complications, Residual stenosis after intervention measured on angiography, Incidence of periprocedural complications including bleeding vascular complications or arrhythmias, Individual components of major adverse cardiac events including all cause mortality myocardial infarction and target lesion revascularization,Timepoint: During procedure and at hospital discharge | — |
Countries
India
Contacts
Rhythm Heart and Critical Care